Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 13/20 | 0.63 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.63 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.63 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.56 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.56 |
| ▸ | PDE2A | O00408 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | PNP | P00491 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.54 |
| ▸ | HSP90B1 | P14625 | 2/20 | 0.54 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3746582 | 1.00 | ADORA3 (0.63) | ADORA3ADORA2AADORA1PDE4DPDE3A | |
| SCHEMBL3740999 | 1.00 | ADORA3 (0.63) | ADORA3ADORA2AADORA1PDE4DPDE3A | |
| SCHEMBL5361537 | 1.00 | ADORA3 (0.63) | ADORA3ADORA2AADORA1PDE4DPDE3A | |
| SCHEMBL7768864 | 1.00 | ADORA3 (0.63) | ADORA3ADORA2AADORA1PDE4DPDE3A | |
| SCHEMBL14518668 | 1.00 | ADORA3 (0.63) | ADORA3ADORA2AADORA1PDE4DPDE3A | |
| SCHEMBL8215936 | 0.90 | ADORA3 (0.62) | ADORA3ADORA2AADORA1PDE4DPDE3A | |
| SCHEMBL8215939 | 0.90 | ADORA3 (0.62) | ADORA3ADORA2AADORA1PDE4DPDE3A | |
| SCHEMBL12636459 | 0.88 | AHCY (0.58) | ADORA3ADORA2AADORA1LMNAHSP90B1 | |
| SCHEMBL8709225 | 0.88 | AHCY (0.58) | ADORA3ADORA2AADORA1LMNAHSP90B1 | |
| SCHEMBL8709942 | 0.88 | AHCY (0.58) | ADORA3ADORA2AADORA1LMNAHSP90B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7838508-B2 | 4′-thio-L-xyloy furanosyl nucleosides, precursors thereof, preparation and use thereof | SOUTHERN RESEARCH INSTITUTE (US) | 2010-11-23 | — | — | US | disclosed |
| US-20070112004-A1 | 4'-THIO-L-XYLOY FURANOSYL NUCLEOSIDES, PRECURSORS THEREOF, PREPARATION AND USE THEREOF | SOUTHERN RESEARCH INSTITUTE (US) | 2007-05-17 | — | — | US | disclosed |
| US-7148223-B2 | Compounds for use as viricides, anticarcinogenic agents and inhibit DNA replication | SOUTHERN RESEARCH INSTITUTE (US) | 2006-12-12 | — | — | US | disclosed |
| US-6914061-B2 | 4′-thio-L-xylofuranosyl nucleosides, precursors thereof, preparation and use thereof | SOUTHERN RESEARCH INSTITUTE (US) | 2005-07-05 | — | — | US | disclosed |
| US-20050130969-A1 | 4'-Thio-L-xyloy furanosyl nucleosides, precursors thereof, preparation and use thereof | SOUTHERN RESEARCH INSTITUTE (US) | 2005-06-16 | — | — | US | disclosed |
| US-20030144235-A1 | Anticarcinogenic agents for treating cancer, a viricides for viral diseases, inhibit DNA replication | SOUTHERN RESEARCH INSTITUTE | 2003-07-31 | — | — | US | disclosed |
| WO-2001066118-A1 | 4'-THIO-L-XYLO FURANOSYL NUCLEOSIDES, PRECURSORS THEREOF, PREPARATION AND USE THEREOF | SOUTHERN RESEARCH INSTITUTE (US) | 2001-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144235-A1 | Anticarcinogenic agents for treating cancer, a viricides for viral diseases, inhibit DNA replication | POLL, PCNA, YWHAZ | ADORA3 2303/4885ADORA2A 3182/4885ADORA1 1407/4885 |
| US-20070112004-A1 | 4'-THIO-L-XYLOY FURANOSYL NUCLEOSIDES, PRECURSORS THEREOF, PREPARATION AND USE THEREOF | POLL, PNP, UNG | ADORA3 694/4885ADORA2A 644/4885ADORA1 516/4885 |
| US-20050130969-A1 | 4'-Thio-L-xyloy furanosyl nucleosides, precursors thereof, preparation and use thereof | POLL, PNP, UNG | ADORA3 694/4885ADORA2A 644/4885ADORA1 516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.